CONCERT PHARMACEUTICALS, INC. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$32.6M

Net Income/Loss (FY2021)

-$80.1M

Total Assets (FY2021)

$165.3M

Total Equity (FY2021)

$112.2M

Cash Flows from Operating Activities (FY2021)

-$55.2M

Source: CONCERT PHARMACEUTICALS, INC. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.